Sudarshan Pharma Board to Consider Q2 Results and Fund Raising
Sudarshan Pharma Industries Ltd 路 Intimation 路 29 Oct 2026, 5:30 am
Sudarshan Pharma Board to Consider Q2 Results and Fund Raising Sudarshan Pharma Industries' Board of Directors is scheduled to meet on 29th Oct'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. The board will also evaluate a proposal for fund raising via equity shares, convertible securities, warrants, or debt instruments through private placement, preferential issue, Qualified Institutions Placement (QIP), or other modes, subject to regulatory approvals. The company's trading window remains closed until 48 hours post the result declaration.
Original exchange filing (PDF)
More announcements from Sudarshan Pharma Industries Ltd
- Pursuant to Regulation 30 and other applicable Regulations, if any, of the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (''SEBI Listing Regulations''), we inform .... 路 09 Nov 2026
- In terms of Regulation 30 read with Para A of Part A of Schedule III to the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, we hereby submit the updated Investor .... 路 07 Nov 2026
- In continuation of the Company''s letter dated 30/Oct/2026 (ref. no. SPIL/CS/2026-2027/72), the Board of Directors at its Meeting held on 29/Oct/2026 have approved the proposal to raising .... 路 31 Oct 2026
- This is to inform you that the Board of Directors of the Company at its Board Meeting held on 29/Oct/2026 has approved the proposal to raising funds through issue and allotment of up to .... 路 30 Oct 2026
- We are submitting herewith the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30/Sep/2026 路 30 Oct 2026
- We are submitting the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30/Sep/2026 路 30 Oct 2026
- Sudarshan Pharma Industries Limited has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Fund raising. 路 29 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 and Fund Raising 路 29 Oct 2026
